Hodgkin's disease

Med Clin North Am. 1984 May;68(3):729-40. doi: 10.1016/s0025-7125(16)31125-7.

Abstract

The outlook for patients with Hodgkin's disease has improved dramatically over the past 20 years. The question is no longer whether cure is possible, but rather, how can cure be best achieved. With better understanding of the biology of Hodgkin's disease and with continued evolution of treatment approaches, the goal of curing all patients with Hodgkin's disease is clearly within reach. This article provides a summary of current concepts in the biology and management of Hodgkin's disease. Staging, treatment options, and complications of therapy are discussed.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Cobalt Radioisotopes / therapeutic use
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / epidemiology
  • Hodgkin Disease / pathology*
  • Hodgkin Disease / radiotherapy
  • Humans
  • Male
  • Mechlorethamine / administration & dosage
  • Middle Aged
  • Neoplasm Staging
  • Neoplasms, Multiple Primary / etiology
  • Particle Accelerators
  • Prednisolone / administration & dosage
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Radioisotope Teletherapy
  • Radiotherapy, High-Energy
  • Vinblastine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Cobalt Radioisotopes
  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Dacarbazine
  • Doxorubicin
  • Prednisolone
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • MOPP protocol
  • MVPP protocol
  • MVVPP protocol